The lisinopril market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising prevalence of hypertension and cardiovascular diseases, generic versions and cost-effectiveness, growing awareness and early diagnosis, growing demand for effective treatments, and aging population. Major trends in the forecast period include innovations in drug delivery, need for enhanced and patient-centric drug delivery approaches, demand for cost-effective solutions, demand for effective treatments for heart failure, and demand for effective treatments for diabetic kidney disease.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/lisinopril-global-market-report
Scope Of Lisinopril Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Lisinopril Market Overview
Market Drivers –
The growing prevalence of cardiovascular diseases is expected to propel the growth of the lisinopril market going forward. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels. The growing prevalence of cardiovascular diseases can be attributed to several factors, such as population growth and aging, risk factors, and lack of implementation of proven prevention and treatment strategies. Lisinopril helps manage cardiovascular diseases primarily through its ability to lower blood pressure and reduce the strain on the heart and kidneys. This inhibits the production of angiotensin II, facilitates the dilation of blood vessels, reduces blood volume, and protects organs from damage. For instance, in May 2022, according to the Centers for Disease Control and Prevention, a US-based governmental organization, the prevalence of coronary heart disease among adults aged 18 and over stood at 4.6% in 2020, experiencing a slight uptick to 4.9% in 2021. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the lisinopril market.
Growing Hypertension Prevalence To Drive Expansion Of The Lisinopril Market
The increasing prevalence of hypertension is expected to propel the growth of the lisinopril market going forward. Hypertension, commonly known as high blood pressure, is a medical condition in which the force of the blood against the walls of the arteries is consistently too high. The rising prevalence of hypertension is due to an unhealthy diet, a sedentary lifestyle, an aging population, and long-term stress. Lisinopril is an effective medication for managing hypertension by blocking the formation of angiotensin II, leading to the relaxation of blood vessels, reduced blood volume, and lower blood pressure. For instance, in March 2023, The World Health Organization, a Switzerland-based health organization, around 1.28 billion adults aged 30–79 years worldwide had hypertension in 2023. Therefore, the increasing prevalence of hypertension drives the lisinopril market.
Market Trends –
The lisinopril market covered in this report is segmented –
1) By Brand: Zestoretic, Prinivil, Zestril, Other Brands
2) By Disease: Hypertension, Heart Failure, Heart Attack, Strokes, Diabetic Kidney Disease, Other Diseases
3) By Dosage: Tablet, Liquid, Other Dosages
4) By Population Type: Children, Adults
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Get an inside scoop of the lisinopril market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16465&type=smp
Regional Insights –
North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc. , AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited , Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences
Table of Contents
1. Executive Summary
2. Lisinopril Market Report Structure
3. Lisinopril Market Trends And Strategies
4. Lisinopril Market – Macro Economic Scenario
5. Lisinopril Market Size And Growth
…..
27. Lisinopril Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Related Reports:
https://goodprnews.com/satellite-based-global-navigation-satellite-system-gnss-augmentation-system-global-market-size/
https://goodprnews.com/social-media-platforms-global-market-size/
https://goodprnews.com/three-dimensional-3d-technology-global-market-size/
https://topprnews.com/satellite-based-global-navigation-satellite-system-gnss-augmentation-system-global-market-share/
https://topprnews.com/social-media-platforms-global-market-share/
https://topprnews.com/three-dimensional-3d-technology-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
